Vertex Pharmaceuticals (VRTX) EBITDA Margin (2009 - 2026)
Vertex Pharmaceuticals' EBITDA Margin was 39.10% in Q2 2026, down 1.48 percentage points from 40.57% a year earlier and down 0.88 percentage points from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vertex Pharmaceuticals' EBITDA Margin was 39.72% through Jun 30, 2026, up 3.61 percentage points year-over-year; for FY2025, it was 36.52%, up 36.76 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -11.27 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -0.23% in FY2024 (-40.90 pp), 40.66% in FY2023 (-9.23 pp), 49.89% in FY2022 (+11.50 pp) and 38.39% in FY2021 (-9.40 pp).
- The Q2 2026 figure marks the lowest quarterly EBITDA Margin since Q1 2025.
- Compared with a year earlier, EBITDA Margin was higher in three of the last eight quarters, with an average year-over-year change of +20.04 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2025 (a gain of 171.38 percentage points); the worst was Q2 2024 (a drop of 173.64 percentage points).
- Per Business Quant data, VRTX's EBITDA Margin in the three quarters before Q2 2026 was 39.97% (Q1 2026), 39.55% (Q4 2025) and 40.31% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 42.49% |
| 10 | Vertex Pharmaceuticals | 137.20 Bn | 109.19 Bn | 2.91 Bn | 22.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 22.73% |
| Jun 30, 2026 | 39.10% |
| Mar 31, 2026 | 39.97% |
| Dec 31, 2025 | 39.55% |
| Sep 30, 2025 | 40.31% |
| Jun 30, 2025 | 40.57% |
| Mar 31, 2025 | 24.49% |
| Dec 31, 2024 | 36.83% |
| Sep 30, 2024 | 42.19% |
| Jun 30, 2024 | -130.81% |
| Mar 31, 2024 | 44.34% |
| Dec 31, 2023 | 41.61% |
| Sep 30, 2023 | 43.50% |
| Jun 30, 2023 | 42.83% |
| Mar 31, 2023 | 34.44% |
| Dec 31, 2022 | 46.55% |
| Sep 30, 2022 | 49.84% |
| Jun 30, 2022 | 52.07% |
| Mar 31, 2022 | 51.34% |
| Dec 31, 2021 | 43.98% |
API Access
Vertex Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();